Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Sol Andres

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Presse Medicale (Paris, France : 1983)|November 23, 2025
Immunotherapy and the heart: Understanding the cardiovascular risks of immune checkpoint inhibitorsMaria Sol Andres, Maria Clara Llamedo, Sivatharshini Ramalingam, et al.
European Heart Journal|May 19, 2026
Dyslipidaemias in cancer patientsMuhummad Sohaib Nazir, Jaimini Cegla, Maria Sol Andres, et al.
Cardio-Oncology (London, England)|April 11, 2024
Cancer therapy related cardiac dysfunction as a result of PanitumumabIsabelle Senechal, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Cardio-Oncology (London, England)|August 22, 2024
Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditisJieli Tong, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Current Oncology Reports|September 24, 2024
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated CardiotoxicityIsabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
Cardio-Oncology (London, England)|March 8, 2024
Late cardiotoxicity related to HER2-targeted cancer therapyIsabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
The American Journal of Cardiology|October 5, 2023
Clinical Utility and Prognostic Value of Coronary Computed Tomography Angiography in Patients With CancerMuhummad Sohaib Nazir, Theodore Murphy, Nana Poku, et al.
Cardio-Oncology (London, England)|July 15, 2024
Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk scoreFiona Fernando, Maria Sol Andres, Simone Claudiani, et al.
Radiology. Cardiothoracic Imaging|January 11, 2024
Echocardiography versus Cardiac MRI for Measurement of Left Ventricular Ejection Fraction in Individuals with Cancer and Suspected CardiotoxicityMuhummad Sohaib Nazir, Joseph Okafor, Theodore Murphy, et al.
Cardio-Oncology (London, England)|November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunctionMaria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Presse Medicale (Paris, France : 1983)|November 23, 2025
Immunotherapy and the heart: Understanding the cardiovascular risks of immune checkpoint inhibitorsMaria Sol Andres, Maria Clara Llamedo, Sivatharshini Ramalingam, et al.
European Heart Journal|May 19, 2026
Dyslipidaemias in cancer patientsMuhummad Sohaib Nazir, Jaimini Cegla, Maria Sol Andres, et al.
Cardio-Oncology (London, England)|April 11, 2024
Cancer therapy related cardiac dysfunction as a result of PanitumumabIsabelle Senechal, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Cardio-Oncology (London, England)|August 22, 2024
Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditisJieli Tong, Nikolaos Vogiatzakis, Maria Sol Andres, et al.
Current Oncology Reports|September 24, 2024
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated CardiotoxicityIsabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
Cardio-Oncology (London, England)|March 8, 2024
Late cardiotoxicity related to HER2-targeted cancer therapyIsabelle Senechal, Maria Sol Andres, Jieli Tong, et al.
The American Journal of Cardiology|October 5, 2023
Clinical Utility and Prognostic Value of Coronary Computed Tomography Angiography in Patients With CancerMuhummad Sohaib Nazir, Theodore Murphy, Nana Poku, et al.
Cardio-Oncology (London, England)|July 15, 2024
Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk scoreFiona Fernando, Maria Sol Andres, Simone Claudiani, et al.
Radiology. Cardiothoracic Imaging|January 11, 2024
Echocardiography versus Cardiac MRI for Measurement of Left Ventricular Ejection Fraction in Individuals with Cancer and Suspected CardiotoxicityMuhummad Sohaib Nazir, Joseph Okafor, Theodore Murphy, et al.
Cardio-Oncology (London, England)|November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunctionMaria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
Pageof 2